Biotech Values

[Nerf]

RPRX rfj:

I also, am encouraged to see you thinking along those lines. I would be encouraged by just about anyone writing those thoughts and someone like you, who obviously follows the space closely is even more exciting.

I am wondering if you have given any thought to trying to establish a more accurate value for RPRX?

I mean 250 ++ is a really nice thought, but given that myogen sold for $1.5 (?) B with several months to go to end of PIII trial and full writeups submitted (along the lines of RPRX in the srping next year) where little old 134M Repros might be after the summer is over..... exactly how many "+++" 's do we add?

I'd hate to toss out a number without seeing some more as well....let's just say that I think this is one of the rare opportunities for a "little guy" to make some really good returns.

And the "proellex alone" comment is also encouraging...I see androxal, worldwide agent as being at least $200 by itself, very conservatively. It boggles the mind to think how much upside might be here.


Disclosure: Long RPRX since $7 to $13 back to $6, back to $14 back to $10....... sigh